Immix Biopharma (IMMX) Enterprise Value (2020 - 2026)
Quarterly results put Enterprise Value at -$90.6 million for Q1 2026, down 468.93% from a year ago — trailing twelve months through Mar 2026 was -$90.6 million (down 468.93% YoY), and the annual figure for FY2025 was -$100.4 million, down 467.97%.
Immix Biopharma has reported Enterprise Value over the past 7 years, most recently at -$90.6 million for Q1 2026.
- Enterprise Value reached -$90.6 million in Q1 2026 per IMMX's latest filing, up from -$100.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11.5 million in Q1 2023 and bottomed at -$100.4 million in Q4 2025.
- Median Enterprise Value over the past 5 years was -$18.1 million (2022), compared with a mean of -$27.6 million.
- The largest annual shift saw Enterprise Value surged 51.62% in 2025 before it tumbled 468.93% in 2026.
- Over 5 years, Enterprise Value stood at -$16.9 million in 2022, then fell by 4.7% to -$17.7 million in 2023, then increased by 0.17% to -$17.7 million in 2024, then tumbled by 467.97% to -$100.4 million in 2025, then rose by 9.81% to -$90.6 million in 2026.
- Business Quant data shows Enterprise Value for IMMX at -$90.6 million in Q1 2026, -$100.4 million in Q4 2025, and -$15.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | -90.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.58 Mn |
| Dec 31, 2025 | -100.43 Mn |
| Sep 30, 2025 | -15.90 Mn |
| Jun 30, 2025 | -11.60 Mn |
| Mar 31, 2025 | -15.92 Mn |
| Dec 31, 2024 | -17.68 Mn |
| Sep 30, 2024 | -19.69 Mn |
| Jun 30, 2024 | -23.98 Mn |
| Mar 31, 2024 | -29.60 Mn |
| Dec 31, 2023 | -17.71 Mn |
| Sep 30, 2023 | -19.71 Mn |
| Jun 30, 2023 | -12.71 Mn |
| Mar 31, 2023 | -11.50 Mn |
| Sep 30, 2022 | -16.92 Mn |
| Jun 30, 2022 | -18.40 Mn |
| Mar 31, 2022 | -19.06 Mn |
| Dec 31, 2021 | -17.64 Mn |
| Dec 31, 2020 | -391,086.00 |